These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21496594)

  • 1. Drug-induced hyperkinetic movement disorders by nonneuroleptic agents.
    Zesiewicz TA; Sullivan KL
    Handb Clin Neurol; 2011; 100():347-63. PubMed ID: 21496594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and subacute drug-induced movement disorders.
    Burkhard PR
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S108-12. PubMed ID: 24262159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
    Chen JJ; Ondo WG; Dashtipour K; Swope DM
    Clin Ther; 2012 Jul; 34(7):1487-504. PubMed ID: 22749259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hyperkinetic movement disorders.
    Jankovic J
    Lancet Neurol; 2009 Sep; 8(9):844-56. PubMed ID: 19679276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hyperkinetic movement disorders.
    Bressman SB; Greene PE
    Neurol Clin; 1990 Feb; 8(1):51-75. PubMed ID: 2181268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pearls: hyperkinetic movement disorders.
    Reich SG
    Semin Neurol; 2010 Feb; 30(1):15-22. PubMed ID: 20127576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrabenazine in the treatment of hyperkinetic movement disorders.
    Kenney C; Jankovic J
    Expert Rev Neurother; 2006 Jan; 6(1):7-17. PubMed ID: 16466307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.
    Kenney C; Hunter C; Jankovic J
    Mov Disord; 2007 Jan; 22(2):193-7. PubMed ID: 17133512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tardive tremor.
    Stacy M; Jankovic J
    Mov Disord; 1992; 7(1):53-7. PubMed ID: 1348352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [
    Timmers ER; Klamer MR; Marapin RS; Lammertsma AA; de Jong BM; Dierckx RAJO; Tijssen MAJ
    Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):1954-1973. PubMed ID: 36702928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperkinetic dysarthria as an early indicator of impending tardive dyskinesia.
    Portnoy RA
    J Speech Hear Disord; 1979 May; 44(2):214-9. PubMed ID: 502488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuropharmacology of tardive dyskinesia, spontaneous dyskinesia, and other dystonias.
    Stahl SM; Davis KL; Berger PA
    J Clin Psychopharmacol; 1982 Oct; 2(5):321-8. PubMed ID: 6127351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scales for hyperkinetic disorders: A systematic review.
    Pietracupa S; Bruno E; Cavanna AE; Falla M; Zappia M; Colosimo C
    J Neurol Sci; 2015 Nov; 358(1-2):9-21. PubMed ID: 26428309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome.
    Kompoliti K; Goetz CG
    Mov Disord; 1998 May; 13(3):477-80. PubMed ID: 9613740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric movement disorders.
    Saunders-Pullman R; Braun I; Bressman S
    Child Adolesc Psychiatr Clin N Am; 1999 Oct; 8(4):747-65, viii. PubMed ID: 10553201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug treatment of hyperkinetic movement disorders.
    Fahn S
    Semin Neurol; 1987 Jun; 7(2):192-208. PubMed ID: 3332454
    [No Abstract]   [Full Text] [Related]  

  • 17. New nomenclature for drug-induced movement disorders including tardive dyskinesia.
    Chouinard G
    J Clin Psychiatry; 2004; 65 Suppl 9():9-15. PubMed ID: 15189106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders.
    Jankovic J; Clarence-Smith K
    Expert Rev Neurother; 2011 Nov; 11(11):1509-23. PubMed ID: 22014129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperkinetic movement disorders associated with HIV and other viral infections.
    Carroll E; Sanchez-Ramos J
    Handb Clin Neurol; 2011; 100():323-34. PubMed ID: 21496592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep brain stimulation for hyperkinetics disorders: dystonia, tardive dyskinesia, and tics.
    Welter ML; Grabli D; Vidailhet M
    Curr Opin Neurol; 2010 Aug; 23(4):420-5. PubMed ID: 20610993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.